Summary
Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of atopic comorbidities that they had, according to data published in Annals of Allergy,
Source: Healio
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
